Validation pour Ingenuity440

vers la météo de la validation par utilisateur

Ingenuity440

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 90 - PMID ?

zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti SP NODE protein antibody .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

            +--------------------------------------SUBJ:V-N--------------------------------------+                              
            +-------------------------OBJ:V-N------------------------+                           |                              
            |                     +-------------SUBJ:V-N-------------+                           |                              
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               +-----COMP:V-N(by)----+     +----OBJ:V-N----+              
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+               |             +MOD_ATT+     |       +MOD_ATT+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,anti)
MOD_ATT:N-ADJ (anti,monoclonal)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 1

            +------------------------------------------SUBJ:V-N------------------------------------------+                      
            +-------------------------OBJ:V-N------------------------+                                   |                      
            |                     +-------------SUBJ:V-N-------------+--------COMP:V-N(by)-------+       |                      
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               |             +MOD_ATT:N-ADJ+       |                      
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+               |             |       +MOD_A+       +OBJ:V-N+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,__SP__)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 2

            +--------------------------------------SUBJ:V-N--------------------------------------+                              
            +-------------------------OBJ:V-N------------------------+                           |                              
            |                     +-------------SUBJ:V-N-------------+                           |                              
            |                     +----------SUBJ:V-N----------+     |                           |                              
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+         |     +-----COMP:V-N(by)----+     +----OBJ:V-N----+              
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+         |     |             +MOD_ATT+     |       +MOD_ATT+              
  |  |      |       |    |        |            |     |         |     |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
SUBJ:V-N (be,progression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,anti)
MOD_ATT:N-ADJ (anti,monoclonal)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 3

            +--------------------------------------SUBJ:V-N--------------------------------------+                              
            +-------------------------OBJ:V-N------------------------+                           |                              
            |                     +-------------SUBJ:V-N-------------+                           |                              
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               +-----COMP:V-N(by)----+     +----OBJ:V-N----+              
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+               |             +MOD_ATT+     |       +MOD_ATT+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,anti)
MOD_ATT:N-ADJ (anti,monoclonal)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 4

            +------------------------------------------SUBJ:V-N------------------------------------------+                      
            +-------------------------OBJ:V-N------------------------+                                   |                      
            |                     +-------------SUBJ:V-N-------------+                                   |                      
            |                     +----------SUBJ:V-N----------+     +--------COMP:V-N(by)-------+       |                      
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+         |     |             +MOD_ATT:N-ADJ+       |                      
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+         |     |             |       +MOD_A+       +OBJ:V-N+              
  |  |      |       |    |        |            |     |         |     |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
SUBJ:V-N (be,progression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,__SP__)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 5

            +------------------------------------------SUBJ:V-N------------------------------------------+                      
            +-------------------------OBJ:V-N------------------------+                                   |                      
            |                     +-------------SUBJ:V-N-------------+--------COMP:V-N(by)-------+       |                      
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               |             +MOD_ATT:N-ADJ+       |                      
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+               |             |       +MOD_A+       +OBJ:V-N+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,__SP__)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 6

  +---------MOD_ATT:N-ADJ---------+                                                                                             
  |  +---------MOD_ATT:N-N--------+                                                                                             
  |  |      +-----MOD_ATT:N-N-----+-------------SUBJ:V-N-------------+------------------OBJ:V-N------------------+              
  |  |      |       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               +-----COMP:V-N(by)----+     +-MOD_ATT:N-ADJ-+              
  |  |      |       |    +MOD_ATT:+            +MOD_A+               |             +MOD_ATT+     |       +MOD_ATT+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (progression,zD)
MOD_ATT:N-N (progression,fmk)
MOD_ATT:N-N (progression,decrease)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (anti,monoclonal)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 7

  +---------MOD_ATT:N-ADJ---------+                                                                                             
  |  +---------MOD_ATT:N-N--------+                                  +------------------OBJ:V-N------------------+              
  |  |      +-----MOD_ATT:N-N-----+-------------SUBJ:V-N-------------+--------COMP:V-N(by)-------+               |              
  |  |      |       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               |             +MOD_ATT:N-ADJ+               |              
  |  |      |       |    +MOD_ATT:+            +MOD_A+               |             |       +MOD_A+       +MOD_ATT+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (progression,zD)
MOD_ATT:N-N (progression,fmk)
MOD_ATT:N-N (progression,decrease)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,__SP__)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 8

  +---------MOD_ATT:N-ADJ---------+                                                                                             
  |  +---------MOD_ATT:N-N--------+-------------SUBJ:V-N-------------+                                                          
  |  |      +-----MOD_ATT:N-N-----+----------SUBJ:V-N----------+     +------------------OBJ:V-N------------------+              
  |  |      |       +-MOD_ATT:N-N-+---COMP:N-N(of)---+         |     +-----COMP:V-N(by)----+     +-MOD_ATT:N-ADJ-+              
  |  |      |       |    +MOD_ATT:+            +MOD_A+         |     |             +MOD_ATT+     |       +MOD_ATT+              
  |  |      |       |    |        |            |     |         |     |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (progression,zD)
MOD_ATT:N-N (progression,fmk)
MOD_ATT:N-N (progression,decrease)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
SUBJ:V-N (be,progression)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (anti,monoclonal)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 9

  +---------MOD_ATT:N-ADJ---------+                                                                                             
  |  +---------MOD_ATT:N-N--------+                                                                                             
  |  |      +-----MOD_ATT:N-N-----+-------------SUBJ:V-N-------------+------------------OBJ:V-N------------------+              
  |  |      |       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               +-----COMP:V-N(by)----+     +-MOD_ATT:N-ADJ-+              
  |  |      |       |    +MOD_ATT:+            +MOD_A+               |             +MOD_ATT+     |       +MOD_ATT+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (progression,zD)
MOD_ATT:N-N (progression,fmk)
MOD_ATT:N-N (progression,decrease)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,anti)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (anti,monoclonal)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 10

  +---------MOD_ATT:N-ADJ---------+                                                                                             
  |  +---------MOD_ATT:N-N--------+-------------SUBJ:V-N-------------+------------------OBJ:V-N------------------+              
  |  |      +-----MOD_ATT:N-N-----+----------SUBJ:V-N----------+     +--------COMP:V-N(by)-------+               |              
  |  |      |       +-MOD_ATT:N-N-+---COMP:N-N(of)---+         |     |             +MOD_ATT:N-ADJ+               |              
  |  |      |       |    +MOD_ATT:+            +MOD_A+         |     |             |       +MOD_A+       +MOD_ATT+              
  |  |      |       |    |        |            |     |         |     |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (progression,zD)
MOD_ATT:N-N (progression,fmk)
MOD_ATT:N-N (progression,decrease)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
SUBJ:V-N (be,progression)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,__SP__)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 11

  +---------MOD_ATT:N-ADJ---------+                                                                                             
  |  +---------MOD_ATT:N-N--------+                                  +------------------OBJ:V-N------------------+              
  |  |      +-----MOD_ATT:N-N-----+-------------SUBJ:V-N-------------+--------COMP:V-N(by)-------+               |              
  |  |      |       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               |             +MOD_ATT:N-ADJ+               |              
  |  |      |       |    +MOD_ATT:+            +MOD_A+               |             |       +MOD_A+       +MOD_ATT+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (progression,zD)
MOD_ATT:N-N (progression,fmk)
MOD_ATT:N-N (progression,decrease)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
SUBJ:V-N (increase,progression)
COMP:V-N(by) (increase,__SP__)
OBJ:V-N (increase,protein)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 12

            +--------------------------------------SUBJ:V-N--------------------------------------+                              
            +---------------------------------COMP:N-N(by)---------------------------------+     |                              
            +-------------------------OBJ:V-N------------------------+                     |     |                              
            |                     +-------------SUBJ:V-N-------------+                     |     |                              
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               |                     |     +----OBJ:V-N----+              
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+               |             +MOD_ATT+     |       +MOD_ATT+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
COMP:N-N(by) (decrease,anti)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
MOD_ATT:N-ADJ (anti,monoclonal)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 13

            +------------------------------------------SUBJ:V-N------------------------------------------+                      
            +------------------------------------COMP:N-N(by)------------------------------------+       |                      
            +-------------------------OBJ:V-N------------------------+                           |       |                      
            |                     +-------------SUBJ:V-N-------------+                           |       |                      
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               |             +MOD_ATT:N-ADJ+       |                      
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+               |             |       +MOD_A+       +OBJ:V-N+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
COMP:N-N(by) (decrease,__SP__)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 14

            +--------------------------------------SUBJ:V-N--------------------------------------+                              
            +---------------------------------COMP:N-N(by)---------------------------------+     |                              
            +-------------------------OBJ:V-N------------------------+                     |     |                              
            |                     +-------------SUBJ:V-N-------------+                     |     |                              
            |                     +----------SUBJ:V-N----------+     |                     |     |                              
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+         |     |                     |     +----OBJ:V-N----+              
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+         |     |             +MOD_ATT+     |       +MOD_ATT+              
  |  |      |       |    |        |            |     |         |     |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
COMP:N-N(by) (decrease,anti)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
SUBJ:V-N (be,progression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
MOD_ATT:N-ADJ (anti,monoclonal)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 15

            +--------------------------------------SUBJ:V-N--------------------------------------+                              
            +---------------------------------COMP:N-N(by)---------------------------------+     |                              
            +-------------------------OBJ:V-N------------------------+                     |     |                              
            |                     +-------------SUBJ:V-N-------------+                     |     |                              
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               |                     |     +----OBJ:V-N----+              
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+               |             +MOD_ATT+     |       +MOD_ATT+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
COMP:N-N(by) (decrease,anti)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
MOD_ATT:N-ADJ (anti,monoclonal)
SUBJ:V-N (__SP__,decrease)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 16

            +------------------------------------------SUBJ:V-N------------------------------------------+                      
            +------------------------------------COMP:N-N(by)------------------------------------+       |                      
            +-------------------------OBJ:V-N------------------------+                           |       |                      
            |                     +-------------SUBJ:V-N-------------+                           |       |                      
            |                     +----------SUBJ:V-N----------+     |                           |       |                      
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+         |     |             +MOD_ATT:N-ADJ+       |                      
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+         |     |             |       +MOD_A+       +OBJ:V-N+              
  |  |      |       |    |        |            |     |         |     |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
COMP:N-N(by) (decrease,__SP__)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
SUBJ:V-N (be,progression)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)

Analyse 17

            +------------------------------------------SUBJ:V-N------------------------------------------+                      
            +------------------------------------COMP:N-N(by)------------------------------------+       |                      
            +-------------------------OBJ:V-N------------------------+                           |       |                      
            |                     +-------------SUBJ:V-N-------------+                           |       |                      
  +MOD_ATT:N+       +-MOD_ATT:N-N-+---COMP:N-N(of)---+               |             +MOD_ATT:N-ADJ+       |                      
  |  +MOD_AT+       |    +MOD_ATT:+            +MOD_A+               |             |       +MOD_A+       +OBJ:V-N+              
  |  |      |       |    |        |            |     |               |             |       |     |       |       |              
 zD fmk decreases cell cycle progression of glioma cells that is increased by monoclonal anti __SP__ __NODE__ protein antibody .
MOD_ATT:N-ADJ (decrease,zD)
MOD_ATT:N-N (decrease,fmk)
COMP:N-N(by) (decrease,__SP__)
MOD_ATT:N-N (progression,cell)
MOD_ATT:N-N (progression,cycle)
COMP:N-N(of) (progression,cell)
MOD_ATT:N-N (cell,glioma)
OBJ:V-N (increase,decrease)
SUBJ:V-N (increase,progression)
MOD_ATT:N-ADJ (__SP__,monoclonal)
MOD_ATT:N-N (__SP__,anti)
SUBJ:V-N (__NODE__,decrease)
OBJ:V-N (__NODE__,protein)